Cetera Advisor Networks LLC Vbi Vaccines Inc Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.66 - $1.81 $4,290 - $11,765	-6,500 Reduced 37.54%	10,815 $9,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $1,270 - $2,470	-1,000 Reduced 5.46%	17,315 $29,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $2,210 - $3,220	1,000 Added 5.78%	18,315 $43,000
Q3 2021 Nov 16, 2021	SELL	$2.8 - $3.72 $1,400 - $1,860	-500 Reduced 2.81%	17,315 $54,000
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $2,770 - $6,170	-1,000 Reduced 5.31%	17,815 $51,000
Q2 2020 Aug 13, 2020	SELL	$0.87 - $3.13 $17,214 - $61,933	-19,787 Reduced 51.26%	18,815 $58,000
Q4 2019 Feb 10, 2020	BUY	$0.48 - $1.38 $9,031 - $25,964	18,815 Added 95.09%	38,602 $54,000
Q2 2019 Aug 12, 2019	BUY	$0.65 - $2.12 $12,861 - $41,948	19,787 New	19,787 $23,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.